Stock NKTX NKARTA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Nkarta, Inc.

Equities

NKTX

US65487U1088

Real-time Estimate Cboe BZX
Other stock markets
 13:49:00 2024-06-27 EDT 		5-day change 1st Jan Change
5.72 USD -4.19% Intraday chart for Nkarta, Inc. +8.03% -13.33%
04:09pm Nkarta Initiates Trial of Cell Therapy to Treat Lupus Nephritis; FDA Clears Second Application MT
12:00pm Nkarta, Inc. Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Nkarta, Inc. - Special Call
Transcript : Nkarta, Inc. - Special Call
Transcript : Nkarta, Inc. - Special Call
Transcript : Nkarta, Inc. - Special Call
Transcript : Nkarta, Inc. - Shareholder/Analyst Call
Transcript : Nkarta, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 03:30 PM
Transcript : Nkarta, Inc. - Special Call
Transcript : Nkarta, Inc. Presents at Barclays Global Healthcare Conference 2021, Mar-11-2021 10:20 AM
Transcript : Nkarta, Inc. Presents at Jefferies Cell Therapy Summit 2020, Oct-06-2020 04:30 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NKTX Stock
  4. News Nkarta, Inc.
  5. Transcripts